AGP Executive Report
Last update: 9 minutes agoFederal Courts & Rescheduling: MMJ International Holdings says multiple federal proceedings are testing whether the government followed the law when it moved cannabis toward Schedule III, with challenges spanning a D.C. Circuit rescheduling fight, DEA bulk-manufacturer registration, and a Medicare reimbursement appeal. THC Drinks Go Mainstream: At Lollapalooza, 21+ fans can buy 5mg hemp-derived THC canned cocktails for the first time on festival grounds, fueling a new “drink culture” conversation. Texas Hemp Crackdown: New rules take effect in Texas banning several hemp-derived THC products (including delta-8/delta-10) while delta-9 (≤0.3%) remains legal, with felony exposure for banned items. Utah Access Expansion: Utah opens applications for a second independent medical cannabis pharmacy in a medically underserved/rural area, aiming to cut long travel times. Ghana Licenses Medicinal Cultivation: NACOC awards Ghana’s first cannabis cultivation licences (≤0.3% THC) to two companies for medicinal/industrial use. Product Matching for CBD/CB2: Cannanda launches an interactive “Wellness Finder” to recommend CB2 oil products based on goals and lifestyle. Ohio Market Integration: Ohio HB611 advances, expanding how certain medical marijuana processors can enter adult-use via new licensing pathways. Public Safety & Enforcement: NACOC arrests 10 over alleged cannabis peddling on a university campus; police also report major drug seizures tied to cannabis-infused trafficking networks.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.